Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

"The quality of the report is the holdup. People like Dr. Michael Osterholm, Director of the Center for Infectious Disease Research & Policy at U of MN have been saying for months that most of what is coming out is crap & shouldn’t be published. In light of criticism like that I’m glad that IPIX is getting it right the first time, even if it’s at the expense of greedy investors’ artificial timelines.

Speaking only for myself."

The ceo established the timelines, (there is) nobody else there.